# Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes

> **NCT06439758** · PHASE4 · NOT_YET_RECRUITING · sponsor: **King Saud University** · enrollment: 111 (estimated)

## Conditions studied

- Diabetes Type 2
- Osteoporosis

## Interventions

- **DRUG:** Metformin
- **BEHAVIORAL:** Lifestyle

## Key facts

- **NCT ID:** NCT06439758
- **Lead sponsor:** King Saud University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 111 (ESTIMATED)
- **Last updated:** 2024-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06439758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06439758, "Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06439758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*